4//SEC Filing
Conover Charles 4
Accession 0000930413-12-000229
CIK 0000727510other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:45 PM ET
Size
9.2 KB
Accession
0000930413-12-000229
Insider Transaction Report
Form 4
Conover Charles
SVP, R&D Program Management
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-01-17+25,000→ 25,000 totalExercise: $6.69Exp: 2022-01-17→ Common Stock (25,000 underlying) - Award
Common Stock
2012-01-17+10,000→ 82,213 total
Holdings
- 1,158(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The Restricted Stock Units will vest in three (3) tranches. Of the 10,000 Restricted Stock Units granted, 3,333 will vest on January 17, 2013, 3,333 will vest on January 17, 2014, and 3,334 will vest on January 17, 2015, in each case if the Reporting Person remains employed by the Issuer on such date. The Restricted Stock Units do not have an expiration date.
- [F3]Includes 3,390 shares of Common Stock beneficially owned through a personal joint account with the Reporting Person's spouse.
- [F4]Options granted by Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d).
- [F5]The options will vest in four (4) tranches. Of the 25,000 options granted, 6,250 options will vest on January 17, 2013, 6,250 options will vest on January 17, 2014, 6,250 options will vest on January 17, 2015, and the remaining 6,250 options will vest on January 17, 2016, in each case if the Reporting Person remains employed by the Issuer on such date.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001538563
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:45 PM ET
- Size
- 9.2 KB